Answers are grounded in this paper and cite their sources.
Neonatal screening is a mass examination of newborns that makes it possible to detect congenital and hereditary diseases at an early stage. Since 2023, expanded neonatal screening has been operating in Russia, including the diagnosis of 36 diseases. Objective. To evaluate the effectiveness of the extended neonatal screening program for newborns in the Penza region in 2023–2024. Materials and methods. Samples of the patients’ dry blood stains were used as the material. The diagnosis was carried out by tandem mass spectrometry, polymerase chain reaction, and immunofluorescence analysis. The predictive value indicator and the accurate Fisher test were used for statistical processing. Conclusion. Сalculating the accurate Fisher test and the negative prognostic value, it was found that the expanded neonatal screening program in the Penza Region for 2023–2024 is effective. Despite a low positive predictive value of the expanded neonatal screening, the negative predictive value was high — which offers a high probability of ruling out the condition in the event of a negative results. This underscores the primary role of this program within the early diagnostic system.
No takes yet. Share an insight, caveat, or question.
Krasnova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: